Tumor Ablation Market by Technology (Radiofrequency, Microwave, Cryoablation, IRE, Ultrasound), Mode of treatment (Surgical, Laparoscopic, Percutaneous), Application (Liver, Lung, Kidney, Bone Metastasis, Prostate, Breast) - Global Forecasts to 2020

腫瘍アブレーションの世界市場:高周波アブレーション、マイクロ波アブレーション、冷凍アブレーション、IRE、超音波

◆タイトル:Tumor Ablation Market by Technology (Radiofrequency, Microwave, Cryoablation, IRE, Ultrasound), Mode of treatment (Surgical, Laparoscopic, Percutaneous), Application (Liver, Lung, Kidney, Bone Metastasis, Prostate, Breast) - Global Forecasts to 2020
◆商品コード:MAM-MD-3271
◆調査・発行会社:MarketsandMarkets
◆発行日:2015年3月26日
◆ページ数:242
◆レポート形式:PDF / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD5,650 ⇒換算¥621,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥731,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥896,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、腫瘍アブレーションの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観、産業動向、バリューチェーン分析、市場シェア分析、市場環境分析、技術別分析、治療別分析、用途別分析、地域別分析、市場規模及び予測、競争状況、関連企業分析などの情報をお届けいたします。

・イントロダクション
・エグゼクティブサマリー
・市場インサイト
・市場概観
・産業動向
・バリューチェーン分析
・市場シェア分析
・市場環境分析
・腫瘍アブレーションの世界市場:技術別分析/市場規模
・腫瘍アブレーションの世界市場:治療別分析/市場規模
・腫瘍アブレーションの世界市場:用途別分析/市場規模
・腫瘍アブレーションの世界市場:地域別分析/市場規模
・競争状況
・関連企業分析
...

※上記の和訳は最新内容ではない場合があります。下記の英文概要・目次が最新版です。

The global tumor ablation market is poised to grow at a CAGR of 11.5% during the forecast period (2015-2020), and is expected to reach a value of ~515.2 million by 2020. Although mature markets (such as the U.S., Germany, France, and the U.K.) hold larger shares in the tumor ablation market, the Asia-Pacific region is expected to grow at the highest CAGR in the forecast period. Growth in the tumor ablation market is driven by factors such as growing geriatric population across the world, increasing population base for cancer patients, technological advancements in ablation devices, increasing number of hospitals and surgical and ablation centers, and growing awareness regarding the benefits offered by ablation procedures over those of conventional therapeutic and surgical procedures. However, factors such as cost-containment measures taken by various governments and ongoing healthcare reforms in the U.S. are restraining the growth of this market. In addition, therapeutic challenges related to ablation procedures and stringent regulatory guidelines leading to significant increase in gestation period of product launches are posing significant challenges for the growth of the tumor ablation market.

In this report, the global tumor ablation market is segmented on the basis of technology (radiofrequency ablation, microwave ablation, cryoablation, and other technologies), mode of treatment (surgical, laparoscopic, and percutaneous ablation), and application (liver cancer, lung cancer, kidney cancer, bone metastasis, and other applications). The radiofrequency ablation technology segment accounted for the largest share of the global tumor ablation market in 2014, followed by the microwave ablation technology market. Factors such as significant awareness in the medical community about the application of radiofrequency ablation in cancer treatments, presence of a large number of radiofrequency ablation centers across the globe, and low procedural costs associated with radiofrequency tumor ablation are driving the growth of the radiofrequency tumor ablation market.

Geographically, North America (comprising the U.S. and Canada) commands the largest share of the global tumor ablation market in 2014, followed by Europe. The tumor ablation market in North America is primarily driven by factors such as early introduction and high adoption rate of tumor ablation products in the region, significant trend of replacing older technologies with advanced and innovative therapeutic techniques (such as microwave ablation and cryoablation), and increasing private/public funding to develop and commercialize novel tumor ablation products. However, financial constraints faced by market players are limiting the growth of the tumor ablation market in this region. The Asia-Pacific region is poised to grow at the highest CAGR in the next five years, owing to factors such as large population base paired with high prevalence of various cancers (such as liver, lung, and kidney) in the region, ongoing government initiatives for development and modernization of healthcare infrastructure, increasing adoption due to continuously decreasing prices of tumor ablation products, and rising trends related to localized manufacturing due to growing focus of global giants in the APAC market.

The global tumor ablation market is moderately competitive with various global as well as local market players. As of 2014, the global tumor ablation market was dominated by Medtronic, plc (U.S.), AngioDynamics, Inc. (U.S.), HealthTronics, Inc. (U.S.), Galil Medical, Inc. (U.S.), and Boston Scientific Corporation (U.S.) that together accounted for ~83.0% of the market. New product launches; partnerships, agreements, and collaborations; and strategic acquisitions are the major strategies adopted by most of the market players to achieve growth in the global tumor ablation market.

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis such as industry analysis (industry trends and Porter’s five force model), market share analysis of top ten players, and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging and high-growth segments of the tumor ablation market, and high-growth regions and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helped firms garner higher market shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on tumor ablation products offered by the top 10 players in the global tumor ablation market. The report analyzes the tumor ablation market by technology, mode of treatment, and application across key geographic regions

• Product Development/Innovation: Detailed insights on upcoming tumor ablation technologies, research and development activities, and new product launches in the global tumor ablation market

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various tumor ablation products across key geographic regions

• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global tumor ablation market

• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the global tumor ablation market

【レポートの目次】

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
1.3.3 Years Considered for the Study
1.4 Limitations
1.5 Market Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Factor Analysis
2.3 Market Size Estimation
2.3.1 Top-Down Approach
2.3.2 Bottom-Up Approach
2.4 Market Breakdown and Data Triangulation
2.5 Research Assumptions

3 Executive Summary
3.1 Introduction
3.2 History, Evolution, and Current Scenario
3.3 Future Outlook
3.4 Conclusion

4 Premium Insights

5 Market Overview
5.1 Introduction
5.2 Market Segmentation
5.2.1 Market, By Technology
5.2.2 Market, By Mode of Treatment
5.3.3 Market, By Application
5.3 Market Evolution
5.4 Market Dynamics
5.4.1 Key Market Drivers
5.4.1.1 Growing Geriatric Population Across the World
5.4.1.2 Increasing Population Base for Cancer Patients
5.4.1.3 Technological Advancements in Ablation Devices
5.4.1.4 Sprouting Number of Hospitals, Surgical, and Ablation Centers
5.4.2 Key Market Restraints
5.4.2.1 Cost Containment Measures Taken By Various Governments
5.4.2.2 Ongoing Healthcare Reforms in the U.S.
5.4.3 Key Market Opportunities
5.4.3.1 Growth Potential Offered By Emerging Markets
5.4.3.2 Growing Awareness About Ablation Procedures Over Conventional Therapeutic and Surgical Procedures
5.4.4 Key Market Challenges
5.4.4.1 Stringent Regulatory Guidelines Leading to Significant Increase in Gestation Period of Product Launches

6 Industry Insights
6.1 Introduction
6.2 Value Chain Analysis
6.3 Industry Trends
6.3.1 Growing Adoption Rate of Radiofrequency-Based Tumor Ablation Procedures
6.3.2 Microwave Technology to Be the Fastest Growing Segment in Overall Tumor Ablation Businesses
6.4 Porter’s Five Forces Analysis
6.4.1 Threat From New Entrants
6.4.2 Threat From Substitutes
6.4.3 Bargaining Power of Suppliers
6.4.4 Bargaining Power of Buyers
6.4.5 Intensity of Competitive Rivalry

7 Tumor Ablation Market, By Technology
7.1 Introduction
7.2 Radiofrequency (RF) Ablation
7.3 Microwave Ablation
7.4 Cryoablation
7.5 Other Technologies*

8 Tumor Ablation Market, By Mode of Treatment
8.1 Introduction
8.2 Surgical Ablation
8.3 Laparoscopic Ablation
8.4 Percutaneous Ablation

9 Tumor Ablation Market, By Application
9.1 Introduction
9.2 Liver Cancer
9.3 Lung Cancer
9.4 Kidney Cancer
9.5 Bone Metastasis
9.6 Others**

10 Tumor Ablation Market, By Region
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Italy
10.3.2 Germany
10.3.3 France
10.3.4 U.K.
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Rest of Asia-Pacific
10.5 Rest of the World (RoW)

11 Competitive Landscape
11.1 Introduction
11.2 Market Share Analysis, By Key Players
11.3 Competitive Scenario
11.4 Recent Developments
11.4.1 New Products Launches and Product Enhancements
11.4.2 Agreements, Partnerships, and Agreements
11.4.3 Mergers and Acquisitions
11.4.4 Geographic Expansions
11.4.5 Other Developments

12 Compny Profiles
12.1 Introduction
12.1.1 Geographic Benchmarking
12.1.2 Strategic Benchmarking
12.2 Medtronic, PLC.
12.2.1 Company Overview
12.2.2 MnM Overview
12.2.3 Medtronic, PLC: Company Snapshot
12.2.4 Product Portfolio
12.2.5 Recent Developments (2012-2015)
12.3 Angiodynamics, Inc.
12.3.1 Company Overview
12.3.2 MnM Overview
12.3.3 Angiodynamics, Inc.: Company Snapshot
12.3.4 Product Portfolio
12.3.5 Recent Developments (2012-2015)
12.4 Boston Scientific Corporation
12.4.1 Company Overview
12.4.2 MnM Overview
12.4.3 Boston Scientific Corporation: Company Snapshot
12.4.4 Product Portfolio
12.4.5 Recent Developments (2012-2015)
12.5 Healthtronics, Inc.
12.5.1 Company Overview
12.5.2 MnM Overview
12.5.3 Endo International PLC: Company Snapshot
12.5.4 Product Portfolio
12.5.5 Recent Developments (2012-2015)
12.6 Galil Medical, Inc.
12.6.1 Company Overview
12.6.2 MnM Overview
12.6.3 Product Portfolio
12.6.4 Recent Developments (2012-2015)
12.7 EDAP TMS S.A.
12.7.1 Company Overview
12.7.3 EDAP TMS S.A.: Company Snapshot
12.7.4 Product Portfolio
12.7.5 Recent Developments (2012-2015)
12.8 Mermaid Medical A/S
12.8.1 Company Overview
12.8.2 Product Portfolio
12.8.3 Recent Developments (2012-2015)
12.9 Sonacare Medical, LLC
12.9.1 Company Overview
12.9.2 Product Portfolio
12.9.3 Recent Developments (2012-2015)
12.10 Misonix, Inc.
12.10.1 Company Overview
12.10.2 Misonix, Inc.: Company Snapshot
12.10.3 Product Portfolio
12.10.4 Recent Developments (2012-2015)
12.11 Neuwave Medical, Inc.
12.11.1 Company Overview
12.11.2 Product Portfolio
12.11.3 Recent Developments (2012-2015)

13 Appendix
13.1 Insights From Industry Experts
13.2 Discussion Guide
13.3 Introducing RT: Real Time Market Intelligence
13.4 Available Customizations
13.5 Related Reports

List of Tables (72 Tables)

Table 1 Global Tumor Ablation Market Size, By Technology, 2013-2020 ($Million)
Table 2 Tumor Ablation Market Size for Radiofrequency Ablation Technology, By Region, 2013-2020 ($Million)
Table 3 Tumor Ablation Market Size for Microwave Ablation Technology, By Region, 2013-2020 ($Million)
Table 4 Tumor Ablation Market Size for Cryoablation Technology, By Region, 2013-2020 ($Million)
Table 5 Tumor Ablation Market Size for Other Technologies, By Region, 2013-2020 ($Million)
Table 6 Global Tumor Ablation Market Size, By Mode of Treatment, 2013-2020 ($Million)
Table 7 Market Size for Surgical Ablation Treatment, By Region, 2013-2020 ($Million)
Table 8 Market Size for Laparoscopic Ablation Treatment, By Region, 2013-2020 ($Million)
Table 9 Market Size for Percutaneous Ablation Treatment, By Region, 2013-2020 ($Million)
Table 10 Global Tumor Ablation Market Size, By Application, 2013-2020 ($Million)
Table 11 Tumor Ablation Market Size for Liver Cancer Ablation, By Region, 2013-2020 ($Million)
Table 12 Tumor Ablation Market Size for Lung Cancer Ablation, By Region, 2013-2020 ($Million)
Table 13 Tumor Ablation Market Size for Kidney Cancer Ablation, By Region, 2013-2020 ($Million)
Table 14 Tumor Ablation Market Size for Bone Metastasis Ablation, By Region, 2013-2020 ($Million)
Table 15 Tumor Ablation Market Size for Other Applications, By Region, 2013-2020 ($Million)
Table 16 Tumor Ablation Market Size, By Region, 2013-2020 ($Million)
Table 17 North America: Market Size, By Country, 2013-2020 ($Million)
Table 18 North America: Market Size, By Technology, 2013-2020 ($Million)
Table 19 North America: Market Size, By Mode of Treatment, 2013-2020 ($Million)
Table 20 North America: Market Size, By Application, 2013-2020 ($Million)
Table 21 U.S.: Market Size, By Technology, 2013-2020 ($Million)
Table 22 U.S.: Market Size, By Mode of Treatment, 2013-2020 ($Million)
Table 23 U.S.: Market Size, By Application, 2013-2020 ($Million)
Table 24 Canada: Market Size, By Technology, 2013-2020 ($Million)
Table 25 Canada: Market Size, By Mode of Treatment, 2013-2020 ($Million)
Table 26 Canada: Market Size, By Application, 2013-2020 ($Million)
Table 27 European Tumor Ablation Market Size, By Country, 2013-2020 ($Million)
Table 28 European Tumor Ablation Market Size, By Technology, 2013-2020 ($Million)
Table 29 European Tumor Ablation Market Size, By Mode of Treatment, 2013-2020 ($Million)
Table 30 European Tumor Ablation Market Size, By Application, 2013-2020 ($Million)
Table 31 Italy: Market Size, By Technology, 2013-2020 ($Million)
Table 32 Italy: Market Size, By Mode of Treatment, 2013-2020 ($Million)
Table 33 Italy: Market Size, By Application, 2013-2020 ($Million)
Table 34 Germany: Market Size, By Technology, 2013-2020 ($Million)
Table 35 Germany: Market Size, By Mode of Treatment, 2013-2020 ($Million)
Table 36 Germany: Market Size, By Application, 2013-2020 ($Million)
Table 37 France: Market Size, By Technology, 2013-2020 ($Million)
Table 38 France: Market Size, By Mode of Treatment, 2013-2020 ($Million)
Table 39 France: Market Size, By Application, 2013-2020 ($Million)
Table 40 U.K.: Market Size, By Technology, 2013-2020 ($Million)
Table 41 U.K.: Market Size, By Mode of Treatment, 2013-2020 ($Million)
Table 42 U.K.: Market Size, By Application, 2013-2020 ($Million)
Table 43 Spain: Market Size, By Technology, 2013-2020 ($Million)
Table 44 Spain: Market Size, By Mode of Treatment, 2013-2020 ($Million
Table 45 Spain: Market Size, By Application, 2013-2020 ($Million)
Table 46 Rest of Europe: Market Size, By Technology, 2013-2020 ($Million)
Table 47 Rest of Europe: Market Size, By Mode of Treatment, 2013-2020 ($Million)
Table 48 Rest of Europe: Market Size, By Application, 2013-2020 ($Million)
Table 49 Asia-Pacific: Market Size, By Country, 2013-2020 ($Million)
Table 50 Asia-Pacific: Market Size, By Technology, 2013-2020 ($Million)
Table 51 Asia-Pacific: Market Size, By Mode of Treatment, 2013-2020 ($Million)
Table 52 Asia-Pacific: Market Size, By Application, 2013-2020 ($Million)
Table 53 Japan: Market Size, By Technology, 2013-2020 ($Million)
Table 54 Japan: Market Size, By Mode of Treatment, 2013-2020 ($Million)
Table 55 Japan: Market Size, By Application, 2013-2020 ($Million)
Table 56 China: Market Size, By Technology, 2013-2020 ($Million)
Table 57 China: Market Size, By Mode of Treatment, 2013-2020 ($Million)
Table 58 China: Market Size, By Application, 2013-2020 ($Million)
Table 59 India: Market Size, By Technology, 2013-2020 ($Million)
Table 60 India: Market Size, By Mode of Treatment, 2013-2020 ($Million)
Table 61 India: Market Size, By Application, 2013-2020 ($Million)
Table 62 Rest of Asia-Pacific: Market Size, By Technology, 2013-2020 ($Million)
Table 63 Rest of Asia-Pacific: Market Size, By Mode of Treatment, 2013-2020 ($Million)
Table 64 Rest of Asia-Pacific: Market Size, By Application, 2013-2020 ($Million)
Table 65 RoW: Market Size, By Technology, 2013-2020 ($Million)
Table 66 RoW: Market Size, By Mode of Treatment, 2013-2020 ($Million)
Table 67 RoW: Market Size, By Application, 2013-2020 ($Million)
Table 68 Top 5 New Product Launches and Product Enhancements, 2012–2014
Table 69 Top 5 Agreements, Partnerships, and Collaborations, 2012–2014
Table 70 Top 5 Geographical Expansions, 2012–2014
Table 71 Top 5 Mergers and Acquisitions, 2012–2014
Table 72 Top 5 Other Developments, 2012–2014

List of Figures (86 Figures)

Figure 1 Research Design
Figure 2 Data Triangulation
Figure 3 North America to Hold Largest Share of Tumor Ablation Market During the Forecast Period
Figure 4 RF Ablation to Lead the Revenue Growth of Tumor Ablation Technology Market During 2015-2020
Figure 5 Microwave Ablation Technology to Grow at Fastest CAGR During Study Period
Figure 6 North America to Dominate Surgical Tumor Ablation Treatment Market Till 2020
Figure 7 Liver Cancer to Lead Tumor Ablation Application Market During Forecast Period
Figure 8 Rise in Target Patient Population to Propel the Market Growth of Liver Cancer Ablation in APAC
Figure 9 Increasing Geriatric Population Across Key Mature and Emerging Nations (2012 vs. 2020)
Figure 10 Worldwide Prevalence of Cancer – Expected Trend Till 2020
Figure 11 Tumor Ablation Market, By Technology: Expected Trend During 2013-2020
Figure 12 Market Share: RF Ablation Technology Market, By Region (2015)
Figure 13 Market Share: Microwave Ablation Technology Market, By Region (2015)
Figure 14 Market Share: Cryoablation Technology Market, By Region (2015)
Figure 15 Market Share: Other Ablation Technologies Market, By Region (2015)
Figure 16 Tumor Ablation Market, By Mode of Treatment: Expected Trend During 2013-2020
Figure 17 Market Share: Surgical Ablation Treatment Market, By Region (2015)
Figure 18 Market Share: Laparoscopic Ablation Treatment Market, By Region (2015)
Figure 19 Market Share: Percutaneous Ablation Treatment Market, By Region (2015)
Figure 20 Tumor Ablation Market, By Application: Expected Trend During 2013-2020
Figure 21 Market Share: Liver Cancer Ablation Market, By Region (2015)
Figure 22 Market Share: Lung Cancer Ablation Market, By Region (2015)
Figure 23 Market Share: Kidney Cancer Ablation Market, By Region (2015)
Figure 24 Market Share: Bone Metastasis Ablation Market, By Region (2015)
Figure 25 Market Share: Other Applications Market, By Region (2015)
Figure 26 Key Market Drivers for Global Tumor Ablation Market (2013-2020)
Figure 27 North America: Tumor Ablation Market, Expected Trend (2015 vs. 2020)
Figure 28 North America: Tumor Ablation Market Share, By Technology, 2015
Figure 29 U.S.: Key Market Drivers for Tumor Ablation Market (2013-2020)
Figure 30 U.S.: Tumor Ablation Market Share, By Technology (2015)
Figure 31 U.S.: Market Share, By Mode of Treatment (2015)
Figure 32 U.S.: Market Share, By Application (2015)
Figure 33 Canada: Key Market Drivers for Tumor Ablation Market (2013-2020)
Figure 34 Canada: Tumor Ablation Market Share, By Technology (2015)
Figure 35 Canada: Market Share, By Mode of Treatment (2015)
Figure 36 Canada: Market Share, By Application (2015)
Figure 37 Europe: Tumor Ablation Market, Expected Trend (2015 vs. 2020)
Figure 38 Eu-5: Tumor Ablation Market Share, By Technology, 2015
Figure 39 Italy: Key Market Drivers for Tumor Ablation Market (2013-2020)
Figure 40 Italy: Tumor Ablation Market Share, By Technology (2015)
Figure 41 Italy: Market Share, By Mode of Treatment (2015)
Figure 42 Italy: Market Share, By Application (2015)
Figure 43 Germany: Key Market Drivers for Tumor Ablation Market (2013-2020)
Figure 44 Germany: Tumor Ablation Market Share, By Technology (2015)
Figure 45 Germany: Market Share, By Mode of Treatment (2015)
Figure 46 Germany: Market Share, By Application (2015)
Figure 47 France: Key Market Drivers for Tumor Ablation Market (2013-2020)
Figure 48 France: Tumor Ablation Market Share, By Technology (2015)
Figure 49 France: Market Share, By Mode of Treatment (2015)
Figure 50 France: Market Share, By Application (2015)
Figure 51 U.K.: Key Market Drivers for Tumor Ablation Market (2013-2020)
Figure 52 U.K.: Tumor Ablation Market Share, By Technology (2015)
Figure 53 U.K.: Market Share, By Mode of Treatment (2015)
Figure 54 U.K.: Market Share, By Application (2015)
Figure 55 Spain: Key Market Drivers for Tumor Ablation Market (2013-2020)
Figure 56 Spain: Tumor Ablation Market Share, By Technology (2015)
Figure 57 Spain: Market Share, By Mode of Treatment (2015)
Figure 58 Spain: Market Share, By Application (2015)
Figure 59 RoE: Key Market Drivers for Tumor Ablation Market (2013-2020)
Figure 60 RoE: Tumor Ablation Market Share, By Technology (2015)
Figure 61 RoE: Market Share, By Mode of Treatment (2015)
Figure 62 RoE: Market Share, By Application (2015)
Figure 63 Asia-Pacific: Tumor Ablation Market, Expected Trend (2015 vs. 2020)
Figure 64 Asia-Pacific: Market Share, By Technology, 2015
Figure 65 Japan: Key Market Drivers for Tumor Ablation Market (2013-2020)
Figure 66 Japan: Tumor Ablation Market Share, By Technology (2015)
Figure 67 Japan: Market Share, By Mode of Treatment (2015)
Figure 68 Japan: Market Share, By Application (2015)
Figure 69 China: Key Market Drivers for Tumor Ablation Market (2013-2020)
Figure 70 China: Tumor Ablation Market Share, By Technology (2015)
Figure 71 China: Market Share, By Mode of Treatment (2015)
Figure 72 China: Market Share, By Application (2015)
Figure 73 India: Key Market Drivers for Tumor Ablation Market (2013-2020)
Figure 74 India: Tumor Ablation Market Share, By Technology (2015)
Figure 75 India: Market Share, By Mode of Treatment (2015)
Figure 76 India: Market Share, By Application (2015)
Figure 77 RoAPAC: Key Market Drivers for Tumor Ablation Market (2013-2020)
Figure 78 RoAPAC: Tumor Ablation Market Share, By Technology (2015)
Figure 79 RoAPAC: Market Share, By Mode of Treatment (2015)
Figure 80 RoAPAC: Market Share, By Application (2015)
Figure 81 RoW: Tumor Ablation Market, Expected Trend (2015 vs. 2020)
Figure 82 RoW: Tumor Ablation Market Share, By Technology, 2015
Figure 83 Market Share Analysis: Medtronic, PLC to Lead Tumor Ablation Market Till 2020
Figure 84 Majority of Leading Players Focused on Product Development as Key Growth Strategy to Expand Their Market Share During Study Period
Figure 85 Top 4 Players Generated More Than 3/5th of Their Tumor Ablation Revenue From Americas
Figure 86 Technological Development and Product Enhancement is the Key Strategy Pursued By Top Players to Increase Their Tumor Ablation Market Revenue

【レポートのキーワード】

腫瘍アブレーション、高周波アブレーション、マイクロ波アブレーション、冷凍アブレーション、IRE、超音波、腫瘍アブレーションデバイス、腫瘍アブレーション技術、腫瘍焼灼療法、アブレーション療法、外科的アブレーション、 腹腔鏡下アブレーション、経皮アブレーション、腫瘍治療、医療機器

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[腫瘍アブレーションの世界市場:高周波アブレーション、マイクロ波アブレーション、冷凍アブレーション、IRE、超音波]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆